These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 31134078)
1. Prevention of Pediatric Respiratory Syncytial Virus Lower Respiratory Tract Illness: Perspectives for the Next Decade. Aranda SS; Polack FP Front Immunol; 2019; 10():1006. PubMed ID: 31134078 [TBL] [Abstract][Full Text] [Related]
2. Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia-Implications for Vaccine Design. Rey-Jurado E; Kalergis AM Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28273842 [TBL] [Abstract][Full Text] [Related]
3. Acute lower respiratory infections due to respiratory syncytial virus and adenovirus among hospitalized children from Argentina. Videla C; Carballal G; Misirlian A; Aguilar M Clin Diagn Virol; 1998 May; 10(1):17-23. PubMed ID: 9645999 [TBL] [Abstract][Full Text] [Related]
4. The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines. Wright PF; Karron RA; Belshe RB; Shi JR; Randolph VB; Collins PL; O'Shea AF; Gruber WC; Murphy BR Vaccine; 2007 Oct; 25(42):7372-8. PubMed ID: 17868959 [TBL] [Abstract][Full Text] [Related]
5. Respiratory syncytial virus infections: old challenges and new opportunities. Mejías A; Chávez-Bueno S; Jafri HS; Ramilo O Pediatr Infect Dis J; 2005 Nov; 24(11 Suppl):S189-96, discussion S196-7. PubMed ID: 16378045 [TBL] [Abstract][Full Text] [Related]
6. Risk factors for admission and the role of respiratory syncytial virus-specific cytotoxic T-lymphocyte responses in children with acute bronchiolitis. Jeena PM; Ayannusi OE; Annamalai K; Naidoo P; Coovadia HM; Guldner P S Afr Med J; 2003 Apr; 93(4):291-4. PubMed ID: 12806723 [TBL] [Abstract][Full Text] [Related]
7. Clinical and epidemiologic features of respiratory syncytial virus. Hall CB; Simőes EA; Anderson LJ Curr Top Microbiol Immunol; 2013; 372():39-57. PubMed ID: 24362683 [TBL] [Abstract][Full Text] [Related]
8. Alternative Virus-Like Particle-Associated Prefusion F Proteins as Maternal Vaccines for Respiratory Syncytial Virus. Blanco JCG; Fernando LR; Zhang W; Kamali A; Boukhvalova MS; McGinnes-Cullen L; Morrison TG J Virol; 2019 Dec; 93(23):. PubMed ID: 31511382 [TBL] [Abstract][Full Text] [Related]
16. Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate. Liang B; Surman S; Amaro-Carambot E; Kabatova B; Mackow N; Lingemann M; Yang L; McLellan JS; Graham BS; Kwong PD; Schaap-Nutt A; Collins PL; Munir S J Virol; 2015 Sep; 89(18):9499-510. PubMed ID: 26157122 [TBL] [Abstract][Full Text] [Related]
17. Respiratory Syncytial Virus Genotypes, Host Immune Profiles, and Disease Severity in Young Children Hospitalized With Bronchiolitis. Rodriguez-Fernandez R; Tapia LI; Yang CF; Torres JP; Chavez-Bueno S; Garcia C; Jaramillo LM; Moore-Clingenpeel M; Jafri HS; Peeples ME; Piedra PA; Ramilo O; Mejias A J Infect Dis; 2017 Dec; 217(1):24-34. PubMed ID: 29045741 [TBL] [Abstract][Full Text] [Related]
18. Respiratory syncytial virus vaccines: an update on those in the immediate pipeline. Esposito S; Di Pietro G Future Microbiol; 2016 Oct; 11():1479-1490. PubMed ID: 27750448 [TBL] [Abstract][Full Text] [Related]
19. Immunological mechanisms of severe respiratory syncytial virus bronchiolitis. Bont L; Kimpen JL Intensive Care Med; 2002 May; 28(5):616-21. PubMed ID: 12029411 [TBL] [Abstract][Full Text] [Related]